Characterization of invading glioma cells using molecular analysis of Leading-Edge tissue

Journal of Korean Neurosurgical Society

Volumn 50, Issue 3, 2011, Pages 157-165

  Kim, Cheol Soo ^a   Jung, Shin ^a,b   Jung, Tae Young ^a,b   Jang, Woo Youl ^a   Sun, Heung Suk ^a,b   Ryu, Hyang Hwa ^c  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Chonnam National University   (South Korea)

^c Seonam University   (South Korea)

Author keywords

CD44; Glioma; Laser capture nicrodissection; MMP 2; MMP 9; RHAMM

Indexed keywords

GELATINASE A; GELATINASE B; HERMES ANTIGEN; MESSENGER RNA; RECEPTOR PROTEIN; RHAMM PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE MICRODISSECTION; LASER CAPTURE MICRODISSECTION; MALE; MICRODISSECTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SURGICAL MICROSCOPE; TUMOR CELL; TUMOR CORE CELL; TUMOR MARGINAL CELL; TUMOR RECURRENCE;

EID: 84930475193     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2011.50.3.157     Document Type: Article

References (52)

1. Ahn KY, Park K Y, Kim KK, Kone BC: Chronic hypokalemia enhances expression of the H(+)-K(+)-ATPase alpha 2-submit gene in renal medulla. Am J Physiol 271: F314-F321, 1996
2. Bachelder RE, Marchetti A, Falcioni R, Soddu S, Mercurio AM: Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J Biol Chem 274: 20733-20737, 1999
3. Berens ME, Giese A: " those left behind." Biology and oncology of invasive glioma cells. Neoplasia 1: 208-219, 1999
4. Bignami A, Asher R: Some observations on the localization of hyal-uronic acid in adult, newborn and embryonal rat brain. Int J Dev Neu-rosci 10: 45-57, 1992
5. Bignami A, Hosley M, Dahl D: Hyaluronic acid and hyaluronic acid binding proteins in brain extracellular matrix. Anat Embryol (Berl) 188: 419-433, 1993
6. Bittner M, Meltzer P, Chen Y, Jiang Y, Sefor E, Hendrix M, et al.: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540, 2000
7. Carragher NO, Fincham VJ, Riley D, Frame MC: Cleavage of focal adhesion kinase by diferent proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J Biol Chem 276: 4270-4275, 2001
8. Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535, 2000
9. Copp AJ, Bernfeld M: Accumulation of basement membrane-associated hyaluronate is reduced in the posterior neuropore region of mutant (curly tail) mouse embryos developing spinal neural tube defects. Dev Biol 130: 583-590, 1988
10. Copp AJ, Bernfield M: Glycosaminoglycans vary in accumulation along the neuraxis during spinal neurulation in the mouse embryo. Dev Biol 130: 573-582, 1988
11. Crawford HC, Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14: 234-245, Review, 1994-1995
12. Dalrymple SJ, Parisi JE, Roche PC, Ziesmer SC, Scheithauer BW, Kelly PJ: Changes in proliferating cell nuclear antigen expression in glioblas-toma multiforme cells along a stereotactic biopsy trajectory. Neurosurgery 35: 1036-1044; discussion 1044-1045, 1994
13. Davies B, Miles DW, Happerfeld LC, Naylor MS, Bobrow LG, Rubens RD, et al.: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993
14. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, et al.: Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993
15. De Clerck YA, Shimada H, Gonzalez-Gomez I, Rafel C: Tumoral invasion in the central nervous system. J Neurooncol 18: 111-121, 1994
16. Earnest F 4th, Kelly PJ, Scheithauer B W, Kall BA, Cascino TL, Ehman RL, et al.: Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166: 823-827, 1988
17. Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC Jr, et al.: Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24: 55-57, 1992
18. Gerhards S, Jung K, Koenig F, Daniltchenko D, Hauptmann S, Schnorr D, et al.: Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 57: 675-679, 2001
19. Gliński B, Dymek P, Skołyszewski J: Altered therapy schedules in postoperative treatment of patients with malignant gliomas. Twenty year experience of the Maria Skłodowska-Curie Memorial Center in Kraków, 1973-1993. J Neurooncol 36: 159-165, 1998
20. Grace MB, McLeland CB, Blakely WF: Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. Int J Radiat Biol 78: 1011-1021, 2002
21. Hall CL, Wang C, Lange LA, Turley EA: Hyaluronan and the hyaluro-nan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 126: 575-588, 1994
22. Hernández-Alcoceba R, del Peso L, Lacal JC: Te Ras family of GTPas-es in cancer cell invasion. Cell Mol Life Sci 57: 65-76, 2000
23. Iozzo RV: Proteoglycans: structure, function, and role in neoplasia. Lab Invest 53: 373-396, 1985
24. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer B W, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66: 865-874, 1987
25. Kelly PJ, Daumas-Duport C, Scheithauer B W, Kall BA, Kispert DB: Ereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62: 450-459, 1987
26. Kunishio K, Okada M, Matsumoto Y, Nagao S: Matrix metalloprotein-ase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 20: 39-45, 2003
27. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F: Matrix me-talloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196, 1996
28. Maier D, Jones G, Li X, Schönthal AH, Gratzl O, Van Meir EG, et al.: Te PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 59: 5479-5482, 1999
29. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Kaczmarek E, Ponce F, et al.: Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res 7: 2480-2489, 2001
30. Mariani L, McDonough WS, Hoelzinger DB, Beaudry C, Kaczmarek E, Coons S W, et al.: Identifcation and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res 61: 4190-4196, 2001
31. Mornex F, Nayel H, Taillandier L: Radiation therapy for malignant as-trocytomas in adults. Radiother Oncol 27: 181-192, 1993
32. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR: Forkhead transcription factors are critical efectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20: 8969-8982, 2000
33. Niu M, Nachmias VT: Increased resistance to apoptosis in cells overex-pressing thymosin beta four: a role for focal adhesion kinase pp125FAK. Cell Adhes Commun 7: 311-320, 2000
34. Pauli BU, Schwartz DE, Tonar EJ, Kuettner KE: Tumor invasion and host extracellular matrix. Cancer Metastasis Rev 2: 129-152, 1983
35. Pyke C, Ralfiaer E, Tryggvason K, Danø K: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359-365, 1993
36. Reed JA, Manahan LJ, Park CS, Brigati DJ: Complete one-hour immu-nocytochemistry based on capillary action. Biotechniques 13: 434-443, 1992
37. Samuel SK, Hurta RA, Spearman MA, Wright JA, Turley EA, Greenberg AH: TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 123: 749-758, 1993
38. Silbergeld DL, Chicoine MR: Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86: 525-531, 1997
39. Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA: Matrix me-talloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58: 2209-2216, 1998
40. Tamura M, Gu J, Tran H, Yamada KM: PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91: 1820-1828, 1999
41. Tomas L, Byers HR, Vink J, Stamenkovic I: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971-977, 1992
42. Toole BP: Hyaluronan in morphogenesis. Semin Cell Dev Biol 12: 79-87, Review, 2001
43. Toole BP: Developmental role of hyaluronate. Connect Tissue Res 10: 93-100, 1982
44. Goldberg RL, Seidman JD, Chi-Rosso G, Toole BP: Endogenous hyal-uronate-cell surface interactions in 3T3 and simian virus-transformed 3T3 cells. J Biol Chem 259: 9440-9446, 1984
45. Toole BP, Munaim SI, Welles S, Knudson CB: Hyaluronate-cell interactions and growth factor regulation of hyaluronate synthesis during limb development. Ciba Found Symp 143: 138-145; discussion 145-149, 281-285, 1989
46. Turley EA: Proteoglycans and cell adhesion. Teir putative role during tumorigenesis. Cancer Metastasis Rev 3: 325-339, 1984
47. Turley EA, Austen L, Moore D, Hoare K: Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan- promoted locomotion. Exp Cell Res 207: 277-282, 1993
48. Turley EA, Austen L, Vandeligt K, Clary C: Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-trans-formed cells. J Cell Biol 112: 1041-1047, 1991
49. Vick NA, Paleologos NA: External beam radiotherapy: hard facts and painful realities. J Neurooncol 24: 93-95, 1995
50. Wang M, Wang T, Liu S, Yoshida D, Teramoto A: The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 20: 65-72, 2003
51. Weigel PH, Frost SJ, LeBoeuf RD, McGary CT: Te specific interaction between fbrin(ogen) and hyaluronan: possible consequences in hae-mostasis, inflammation and wound healing. Ciba Found Symp 143: 248-261; discussion 261-264, 281-285, 1989
52. Weigel PH, Fuller GM, LeBoeuf RD: A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Teor Biol 119:219-234, 1986